Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Young women with breast cancer often state they’d like to have children at some point, yet after they’re treated their maintenance therapy may pose barriers. Now a study presented at the San Antonio Breast Cancer Symposium shows that pausing therapy …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Tumor infiltrating lymphocytes, known as TILS, allowed people with advanced melanoma, a serious type of skin cancer, to live longer than those who received an antibody alone, a recent study showed. Kimmel Cancer Center director William Nelson at Johns Hopkins …
Podcast: Download (Duration: 1:00 — 1.4MB)
Subscribe: RSS
So-called ‘bispecific antibodies,’ are racking up some impressive results when it comes to treating certain cancers, recent studies show. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins says making individualized antibodies for cancer treatment as well as …
The blood cancer multiple myeloma largely responds to a specially constructed antibody known as a BITE, for bispecific T cell engager, a recent study shows. Kimmel Cancer Center director William Nelson at Johns Hopkins describes the data. Nelson: In this …
Just how good is a specialized antibody for multiple myeloma? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Antibodies are usually part of our immune response to infections, but now are being constructed in the laboratory to fight cancer, with a recent study demonstrating just how effective they can be against a type of blood cancer. William Nelson, …
Can a unique antibody curb cancer? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
If you have recently been diagnosed with cancer, your best bet for treatment may include enrolling in a clinical trial, where new treatments are being assessed, usually by comparing them with standard treatment. Yet a new study finds that under …
